Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Flanders, Scott C
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. [electronic resource] - Future oncology (London, England) Mar 2018 - 527-536 p. digital
Publication Type: Journal Article
1744-8301
10.2217/fon-2017-0438 doi
Aged
Aged, 80 and over
Comorbidity
Cost of Illness
Humans
Male
Middle Aged
Prostatic Neoplasms, Castration-Resistant--diagnosis
Public Health Surveillance
Quality of Life
Registries
Risk Factors
Socioeconomic Factors
United States--epidemiology
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. [electronic resource] - Future oncology (London, England) Mar 2018 - 527-536 p. digital
Publication Type: Journal Article
1744-8301
10.2217/fon-2017-0438 doi
Aged
Aged, 80 and over
Comorbidity
Cost of Illness
Humans
Male
Middle Aged
Prostatic Neoplasms, Castration-Resistant--diagnosis
Public Health Surveillance
Quality of Life
Registries
Risk Factors
Socioeconomic Factors
United States--epidemiology